Iconovo offers the development of inhalation products — inhaler devices and dry powder formulation — and assists in clinical trials and registration. We also offer proprietary generic drugs. The inhalation platforms are primarily intended for asthma and chronic obstructive pulmonary disease (COPD) treatment.
We work with international generic drug companies and pharmaceutical companies that lack the expertise, resources and/or time to develop the product themselves. Our development time is shorter and consequently more cost-effective since we have ready-to-use platforms with inhalation products that can be modified for a specific drug.
Iconovos highly skilled employees offers a comprehensive service package including device design, formulation development, analytical testing and documentation. Iconovo has build its own state-of-the-art laboratories for analysis, development and characterization of powder formulations.
STEP ONE: Iconovo
• Inhaler device development
STEP TWO: Iconovo
Optimization for Manufacturing
STEP THREE: Iconovo
Optimization with model inhalation powder
STEP FOUR: Iconovo
STEP FIVE: Iconovo
Inhaler device and formulation optimization
STEP SIX: Iconovo with customer
• Technology transfer
• Support and advice to clinical trials and registration
STEP SEVEN: Customer
• Commercial Manufacturing
• Marketing and sales
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
Ideon, Delta 6 Lund
SE-223 70 LUND